<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2017</YEAR>
<VOL>4</VOL>
<NO>1</NO>
<MOSALSAL>0</MOSALSAL>
<PAGE_NO>62</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>Quality assessment of care provided to patients with type 2 diabetes based on Clinical Practice Guidelines </TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Diabetes is one of the usual medical problems that had an important negative effect on patient&#8217;s health. Researches demonstrate that there is a wide gap between recommended medical actions and received care by patients with diabetes. The aim of study was to assess the quality of care provided to patients with type 2 diabetes.

Materials and methods: A cross-sectional study was carried out among 180 people with type 2 diabetes in diabetic&#8217;s clinics using convenience sampling method in Tabriz, Iran in 2011. Using a questionnaire we assessed the reported adherence to minimum recommended annual care for 23 processes indicators based on Iranian Diabetes Guidelines.&#160;

Results: The proportions of the participants who received recommended annual care for all three top clinical and all six top lifestyle indicators were 82.26% and 43.96%, respectively. For lifestyle and management indicators, reported adherence rates to guidelines were low (38.9% for medication review, 67.7% for self-management evaluation, 55% for physical activity review, and 58.3% for nutrition consultation). From the participants&#39; perspective, most of the participants (87%) had well-controlled diabetes.


Conclusion: A substantial proportion of people with type 2 diabetes indicated receiving suboptimal care and there is a notable gap between their expectations and what they have actually received in most aspects of the provided care.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>1</FPAGE>
			<TPAGE>7</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2016/03/8
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1394/12/18
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2016/05/24
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1395/3/4
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Jafar Sadegh</Name>
				<MidName></MidName>
				<Family>Tabrizi</Family>
				<NameE>Jafar Sadegh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tabrizi</FamilyE>
				<Organizations>
				<Organization>Tabriz Health Services Management Research Center, Department of Health Services Management, School of Health Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>js.tabrizi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Yeganeh</Name>
				<MidName></MidName>
				<Family>Partovi</Family>
				<NameE>Yeganeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Partovi</FamilyE>
				<Organizations>
				<Organization>Tabriz Health Services Management Research Center, Department of Health Services Management, School of Health Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>modirpy@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Amir</Name>
				<MidName></MidName>
				<Family>Bahrami</Family>
				<NameE>Amir</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bahrami</FamilyE>
				<Organizations>
				<Organization>Department of Glands, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>modirpy@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad</Name>
				<MidName></MidName>
				<Family>Asghari</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Asghari</FamilyE>
				<Organizations>
				<Organization>Department of Statistics and Epidemiology, Faculty of Health and Nutrition, Tabriz University of Medical sciences, Tabriz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>modirpy@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Type 2 diabetes</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Quality assessment</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Clinical practice guideline</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Larijani B, Zahedi F. [Epidemiology of diabetes mellitus in Iran]. J Diabetes  Lipid   2001;1(1):1-8.(Persian)##2.	LeRoith D, Taylor S, Olefsky J. Diabetes Mellitus. A fundamental and clinical text: Philadelphia: Lippincott Williams and Wilkins; 2004.##3.	Bethel M, Alexander J, Lane J, Barkauskas C, Feinglos M. Diabetes on a cardiovascular ward: adherence to current recommendations. South Med J. 2004; 97(11):1031-7.##4.	ADA. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003; 26:S33-S50.##5.	Knight K, Badamgarav E, Henning J, Hasselblad V, Gano A, Ofman J, et al. A systematic review of diabetes disease management programs. Am J Manag Care. 2005;11(4):242-50. ##6.	Coon P, Zulkowski K. Adherence to American Diabetes Association Standards of Care by rural health care providers. Diabetes Care. 2002; 25(12):2224-9.##7.	Gross R, Tabenkin H, Porath A, Heymann A, Greensein M, Porter B, et al. The relationship between primary care physicians' adherence to guideline for the treatment of diabetes and patients satisfaction: finding from a pilot study. Fam Pract. 2003; 20(5):563-9.##8.	McDermott R, Tulip F, Schmidt B, Siha A. Sustaining better diabetes care in remote indigenous Australian communities. BMJ. 2003;327(7412):428-30.##9.	Kerssens J, Groenewegen P, Sixma H. Comparison of patient evaluations of health care quality in relation to WHO measures of achievement in 12 European countries. Bull World Health Organ. 2004; 82(2):106-14.##10.	Clancy D, Cope D, Magruder K, Huang P, Wolfman T. Evaluating concordance to American Diabetes Association Standards of Care for Type 2 diabetes through group visits in an uninsured or inadequately insured patient population. Diabetic Care. 2003; 26(7):2032-6.##11.	Valk G, Renders C, Kriegsman D, Newton K, Twisk J, Eijk J, et al. Quality of care for patients with type 2 diabetes mellitus in the Netherlands and the United States: a comparison of two quality improvement programs. Health Serv Res. 200439; (4pt 1):709-17.##12.	Kenagy J, Berwick D, Shore M. Service quality in health care. J Am Med Assoc. 1999; 281(7):661-5.##13.	Murray C, Frenk J. A framework for assessing the performance of health systems. Bull World Health Organ. 2000; 78(6):717-32.##14.	Blumental D. Quality of health care. Part 1: quality of care. What is it? N Engl J Med. 1996; 335(12):891-4.##15.	Murray C, Evans DE. Health systems performance assessment: Debates, Methods and Empiricism. 2003.##16.	Delavari A, Mahdi hezave A, Norozi nejad A, Yar ahmadi SH. [National Diabetes Prevention and Control programs]. Second ed. Tehran: Sound Publishing Center; 1383.(Persian)##17.	McGlynn E, Asch S, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003; 348(26):2635-45.##18.	Granville R. Diabetes Mellitus: Diagnosis and Treatment (4th Edition). Bethesda: Association of Military Surgeons of the United States; 1999.##19.	listed Na. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53.##20.	Arday D, Fleming B, Keller D, Pendergrass P, Vaughn R, Turpin J, et al. Variation in diabetes care among states. Diabetes Care. 2002; 25(12):2230-7.##21.	Saaddine J, Engelgau M, Beckles G, Gregg E, Thompson T, Narayan K. A diabetes report card for the United States: quality of care in the 1990s. Ann  Int Med. 2002; 136(8):565-74.##22.	Colagiuri S, Colagiuri R, Ward J. National Diabetes Strategy and Implementation Plan: Diabetes Australia; 1998.##23.	Harris M. Health care and health status and outcomes for patients with Type 2 diabetes. Diabetes Care. 2000; 23(6):754-8.##24.	Pollard G. Queensland Health, 2000 Chronic Diseases Surveys: Diabetes Prevalence and Management Report. 2002. ## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Effect of endurance exercise training on morphological changes in rat heart tissue following experimental myocardial infarction</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Cardiac remodeling after myocardial infarction, is associated with progressive ventricular dysfunction and cardiovascular death. The purpose of this study was to examine the effect of endurance exercise training on morphological changes in rat heart tissue following experimental myocardial infarction.

Materials and methods: Rats used in this experiment (8-10 weeks old, 235 &#177; 5 g body weight) after homogenization according to body weight, were randomly divided to three groups: Healthy (Sham), control (Sedentary) and endurance training groups. Myocardial infarction was induced by subcutaneous injection of isoprenaline (150 mg/kg) in two consecutive days with an interval of 24 hours. Endurance training initiated 2 days after infarction and continued for 4 weeks. In order to assess the necrosis lesion and fibrosis tissue, Hematoxylin&#8211;Eosin and Masson&#39;s trichrome staining were used, respectively. Data were analyzed by using one-way analysis of variance (ANOVA) at P&#60; 0.05 level.

Results: The results indicated that subcutaneous injection of isoprenaline, induced myocardial infarction in rat heart tissue. Rate of necrotic lesion in the Endurance training group was significantly higher than Sedentary (control) group (P=0.005). &#160;&#160;&#160;&#160;&#160;&#160;&#160;Also, the size of fibrosis tissue in the Endurance training group was significantly higher than the sedentary &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(control) group (P= 0.001).

Conclusion: In general, results of this study showed that 4 weeks of endurance exercise training after myocardial infarction exacerbate tissue injury in rat heart.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>8</FPAGE>
			<TPAGE>16</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2016/03/82015/05/24
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1394/3/3
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2016/05/242015/07/26
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1394/5/4
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Akbar</Name>
				<MidName></MidName>
				<Family>Azamian Jazi</Family>
				<NameE>Akbar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Azamian Jazi</FamilyE>
				<Organizations>
				<Organization>Department of Exercise Physiology, Faculty of Literature and Human Sciences, Shahrekord University, Shahrekord, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>abdi_197866@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hadi</Name>
				<MidName></MidName>
				<Family>Abdi</Family>
				<NameE>Hadi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abdi</FamilyE>
				<Organizations>
				<Organization>Department of Physical Education, Payam-e-noor University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>azamianakbar@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad Reza</Name>
				<MidName></MidName>
				<Family>Haffezi Ahmadi</Family>
				<NameE>Mohammad Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Haffezi Ahmadi</FamilyE>
				<Organizations>
				<Organization>Department of Pathobiology, Faculty of Medicine, Ilam University of Medical Science, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>reza.ahmadi56@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Javad</Name>
				<MidName></MidName>
				<Family>Cheraghi</Family>
				<NameE>Javad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Cheraghi</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, Faculty of Veterinary Medicine, Ilam University, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>j.cheraghi@ilam.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Endurance training</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Myocardial infarction</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Morphological changes</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Rat</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Lardizabal JA, Deedwania PC. Benefits of statin therapy and compliance in high risk cardiovascular patients. Vasc Health Risk Manag. 2010;6:843-53. ##2.	Organization WH. World health statistics 2010: World Health Organization; 2010.##3.	Jorge L, Rodrigues B, Rosa KT, Malfitano C, Loureiro TC, Medeiros A, et al. Cardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: role in functional capacity and mortality. Eur Heart J. 2011;32(7):904-12.##4.	Chen CY, Hsu HC, Lee BC, Lin HJ, Chen YH, Huang HC, et al. Exercise training improves cardiac function in infarcted rabbits: involvement of autophagic function and fatty acid utilization. Eur J Heart Fail. 2010;12(4):323-30.##5.	Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res. 2009;81(3):482-90.##6.	Batista DF, Gonçalves AF, Rafacho BP, Santos PP, Minicucci MF, Azevedo PS, et al. Delayed rather than early exercise training attenuates ventricular remodeling after myocardial infarction. Int J Cardiol. 2013;170(1):e3-4.##7.	Jain M, Liao R, Ngoy S, Whittaker P, Apstein CS, Eberli FR. Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats. Cardiovasc Res. 2000;46(1):66-72.##8.	Haykowsky M, Scott J, Esch B, Schopflocher D, Myers J, Paterson I, et al. A meta-analysis of the effects of exercise training on left ventricular remodeling following myocardial infarction: start early and go longer for greatest exercise benefits on remodeling. Trials. 2011; 12:92.##9.	Xu X, Wan W, Ji L, Lao S, Powers AS, Zhao W, et al. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats. Cardiovasc Res. 2008;78(3):523-32.##10.	de Waard MC, van der Velden J, Bito V, Ozdemir S, Biesmans L, Boontje NM, et al. Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction. Circ Res. 2007;100(7):1079-88.##11.	Gaudron P, Hu K, Schamberger R, Budin M, Walter B, Ertl G. Effect of endurance training early or late after coronary artery occlusion on left ventricular remodeling, hemodynamics, and survival in rats with chronic transmural myocardial infarction. Circulation. 1994;89(1):402-12.##12.	Wan W, Powers AS, Li J, Ji L, Erikson JM, Zhang JQ. Effect of post-myocardial infarction exercise training on the renin-angiotensin-aldosterone system and cardiac function. Am J Med Sci. 2007;334(4):265-73.##13.	Orenstein TL, Parker TG, Butany JW, Goodman JM, Dawood F, Wen W-H, et al. Favorable left ventricular remodeling following large myocardial infarction by exercise training. Effect on ventricular morphology and gene expression. J Clin Invest. 1995;96(2):858-66.##14.	Serra AJ, Santos MH, Bocalini DS, Antônio EL, Levy RF, Santos AA, et al. Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained β‐adrenergic hyperactivity. J Physiol. 2010;588(Pt 13):2431-42.##15.	Jugdutt BI, Michorowski BL, Kappagoda CT. Exercise training after anterior Q wave myocardial infarction: importance of regional left ventricular function and topography. J Am Coll Cardiol. 1988;12(2):362-72.##16.	Galvão TF, Matos KC, Brum PC, Negrão CE, Luz PLd, Chagas ACP. Cardioprotection conferred by exercise training is blunted by blockade of the opioid system. Clinics. 2011;66(1):151-7.##17.	Xu X, Zhao W, Lao S, Wilson BS, Erikson JM, Zhang JQ. Effects of exercise and L-arginine on ventricular remodeling and oxidative stress. Med Sci Sports Exerc. 2010;42(2):346-54.##18.	Hammerman H, Schoen FJ, Kloner RA. Short-term exercise has a prolonged effect on scar formation after experimental acute myocardial infarction. J Am Coll Cardiol. 1983;2(5):979-82.##19.	Zaafan MA, Zaki HF, El-Brairy AI, Kenawy SA. Protective effects of atorvastatin and quercetin on isoprenaline-induced myocardial infarction in rats. Bulletin of Faculty of Pharmacy, Cairo University. 2013; 51(1):35-41.##20.	Shukla SK, Sharma SB. β-Adrenoreceptor Agonist Isoproterenol Alters Oxidative Status, Inflammatory Signaling, Injury Markers and Apoptotic Cell Death in Myocardium of Rats. Indian J Clin Biochem. 2015;30(1):27-34.##21.	Zouhal H, Jacob C, Delamarche P, Gratas-Delamarche A. Catecholamines and the effects of exercise, training and gender. Sports Med. 2008;38(5):401-23.##22.	Husain K, Hazelrigg SR. Oxidative injury due to chronic nitric oxide synthase inhibition in rat: effect of regular exercise on the heart. Biochim Biophys Acta. 2002;1587(1):75-82.##23.	Sorescu D, Griendling KK. Reactive oxygen species, mitochondria, and NAD (P) H oxidases in the development and progression of heart failure. Congest Heart Fail. 2002;8(3):132-40.##24.	Dhalla AK, Singal PK. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol. 1994;266(4 Pt 2):H1280-5.##25.	Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol. 1995;27(6):1281-92.##26.	Chiong M, Wang Z, Pedrozo Z, Cao D, Troncoso R, Ibacache M, et al. Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis. 2011;2:e244.##27.	Guazzi M, Tumminello G, Reina G, Vicenzi M, Guazzi M. Atorvastatin therapy improves exercise oxygen uptake kinetics in post‐myocardial infarction patients. Eur J Clin Invest. 2007;37(6):454-62. ## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>E-test antibiotic susceptibility of E.coli strains isolated from hospital acquired infections of Imam Khomeini hospital, Ilam, Iran</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Escherichia coli (E.coli) as a main cause of both nosocomial and community-acquired infections in humans have a relative potential to develop resistance. Nowadays, most infections caused by ESBL-producing E.coli (ESBLEC) had mostly been described as nosocomial acquired or nursing home related. In this study, we employed E-test assay to detect antibiotic resistance of E.coli strains and determine MIC of antibiotics.

Materials and methods: Thirty E.coli strains gathered from Imam Khomeini hospital of Ilam, and cultured on TSB and bacterial suspension prepared by 0.5 &#181;F concentration for E-test. Mueller Hinton agar and E-test strips of Amikacin, Cefepime, Ceftazidime, Ceftriaxone, Gentamicin, Meropenem, Nitrofurantoin, Piperacillin/Tazobactam, Tetracycline, Ticarcillin/ Clavulanic acid, Tobramycin, Trimethoprim were used

Results: Resistance to Ceftriaxone, Tobramycin, Gentamicin, Ticarcillin/ Clavulanic, Amikacin were 19.8%, 26.4%, 23.3%, 62.7%, 70.3%, respectively.


Conclusion: the results indicated, E.coli strains in this study were high sensitivity to Meropenem ,Nitrofuratoin, Ciprofloxacin , Ceftazidime, Cefepime.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>17</FPAGE>
			<TPAGE>21</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2016/03/82015/05/242015/07/5
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1394/4/14
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2016/05/242015/07/262015/10/5
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1394/7/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Lida</Name>
				<MidName></MidName>
				<Family>Bimanand</Family>
				<NameE>Lida</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bimanand</FamilyE>
				<Organizations>
				<Organization>Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>lidabimanand@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Norkhoda</Name>
				<MidName></MidName>
				<Family>Sadeghifard</Family>
				<NameE>Norkhoda</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sadeghifard</FamilyE>
				<Organizations>
				<Organization>Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>pakzadi2006@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Farid</Name>
				<MidName></MidName>
				<Family>Azizi Jalilian</Family>
				<NameE>Farid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Azizi Jalilian</FamilyE>
				<Organizations>
				<Organization>Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>sadehifard@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hassan</Name>
				<MidName></MidName>
				<Family>Hossainzadegan</Family>
				<NameE>Hassan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hossainzadegan</FamilyE>
				<Organizations>
				<Organization>Department  of  Microbiology, Faculty of Nursing , Maragheh University of Medical Sciences,  Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>azizifarid@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Sattar</Name>
				<MidName></MidName>
				<Family>Mohammadi Darbidi</Family>
				<NameE>Sattar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mohammadi Darbidi</FamilyE>
				<Organizations>
				<Organization>Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>pakzadi2006@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ali</Name>
				<MidName></MidName>
				<Family>Hemahian</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hemahian</FamilyE>
				<Organizations>
				<Organization>Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>r.azizian65@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Sobhan</Name>
				<MidName></MidName>
				<Family>Ghafourian</Family>
				<NameE>Sobhan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghafourian</FamilyE>
				<Organizations>
				<Organization>Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mohamadi.sattar@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Iraj</Name>
				<MidName></MidName>
				<Family>Pakzad</Family>
				<NameE>Iraj</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Pakzad</FamilyE>
				<Organizations>
				<Organization>Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>pakzadi2006@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>E-test</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Antibiotic susceptibility</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>E.coli</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ilam</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Iran</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Lark RL, Saint S, Chenoweth C, Zemencuk JK, Lipsky BA, Plorde JJetal. Four-year prospective evaluation of community-acquired bacteraemia: epidemiology, microbiology and patient outcome. DiagnMicrobiol Infect Dis. 2001؛15(2):22-41.##2.	Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother. 2002;46(8):2540-5. ##3.	Foxman B. The epidemiology of urinary tract infection. Nature Rev Urol. 2010;7(12):653-60.##4.	Hisanaga T, Decorby M, Laingk N, editors. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). 41st Annual Meeting of the Infectious Diseases Society of America; 2003;15(3):21-29.##5.	Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999;29(4):745-59.##6.	Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933-51.##7.	Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic–resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 1999;281(6):517-23.##8.	Hadadi A, Rasoulinejad M, Maleki Z, Mojtahedzadeh M, Younesian M, Ahmadi S, et al. [Antimicrobial resistance patterns among Gram-negative bacilli isolated from patients with nosocomial infections: Disk diffusion versus E-test]. Tehran Uni Med J. 2007;65(4):1-10 (Persian).##9.	Torabi S, Falak-ul-Aflaki B, Moezzi F. In vitro Antimicrobial Drug-Resistance of Urinary Tract Pathogens in Patients Admitted to Vali-e-Asr Hospital Wards. ZUMS J. 2007;15(61):79-88.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Effects of Flaxseed oil supplementation on renal dysfunction due to ischemia/reperfusion in rat</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: This study was designed to evaluate the effects of treatment with flaxseed oil (FSO) on renal ischemia-reperfusion (RIR) injuries in rats.

Materials and methods: In this study, 32 Wistar rats were randomly studied in four groups: Co+NS (Control group with normal saline administration), Sh+NS (sham group with normal saline administration), RIR+NS and RIR+FSO. FSO (0.2 ml) was administered orally (gavage) for 14 days (~ 800 mg/kg body weight).&#160; Blood samples were collected for the detection of blood urea nitrogen (BUN) and creatinine levels.&#160; Malondialdehyde (MDA) and superoxide dismutase (SOD) levels were evaluated in the renal tissue. Tubular damages were examined using histopathological studies.

Results: Significantly elevated MDA (P&#60;0.05) and depressed SOD levels (P&#60;0.05) Comparison between RIR+NS group and Control+NS and Sh+NS groups revealed in the condition of RIR. Treatment with FSO, however, significantly lowered the MDA (P&#60;0.05) and enhanced SOD levels (P&#60;0.05) after RIR injury. Histopathological results confirmed the biochemical studies and tubular necrosis score was reduced in the RIR+FSO group.


Conclusion: This study therefore suggests that the aqueous flaxseed oil may be useful agents for the prevention of renal ischemia-reperfusion (RIR)-induced oxidative injury in rats.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>22</FPAGE>
			<TPAGE>29</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2016/03/82015/05/242015/07/52016/05/20
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1395/2/31
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2016/05/242015/07/262015/10/52016/07/16
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1395/4/26
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Tahmineh</Name>
				<MidName></MidName>
				<Family>Mokhtari</Family>
				<NameE>Tahmineh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mokhtari</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mokhtari.tmn@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hedyeh</Name>
				<MidName></MidName>
				<Family>Faghir Ghanesefat</Family>
				<NameE>Hedyeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Faghir Ghanesefat</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mokhtari.tmn@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Gholamreza</Name>
				<MidName></MidName>
				<Family>Hassanzadeh</Family>
				<NameE>Gholamreza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hassanzadeh</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mokhtari.tmn@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ardeshir</Name>
				<MidName></MidName>
				<Family>Moayeri</Family>
				<NameE>Ardeshir</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moayeri</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>moosavimovahed@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Seyed Mohammad Jafar</Name>
				<MidName></MidName>
				<Family>Haeri</Family>
				<NameE>Seyed Mohammad Jafar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Haeri</FamilyE>
				<Organizations>
				<Organization>Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>moosavimovahed@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Alireza</Name>
				<MidName></MidName>
				<Family>Rezaee Kanavee</Family>
				<NameE>Alireza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rezaee Kanavee</FamilyE>
				<Organizations>
				<Organization>Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>moosavimovahed@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Seyyed Majid</Name>
				<MidName></MidName>
				<Family>Mousavi Movahed</Family>
				<NameE>Seyyed Majid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mousavi Movahed</FamilyE>
				<Organizations>
				<Organization>Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>moosavimovahed@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Flaxseed oil</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Renal ischemia-reperfusion</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Oxidative injury</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>MDA</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>SOD</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Functional recovery after partial nephrectomy: effects of volume loss and ischemic injury. J Urol. 2012;187(5):1667-73.##2.	Simmons MN, Schreiber MJ, Gill IS. Surgical renal ischemia: a contemporary overview. J Urol. 2008;180(1):19-30.##3.	Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D, et al. Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol. 2008;3(4):962-7.##4.	Carden DL, Granger DN. Pathophysiology of ischaemia–reperfusion injury. The Journal of pathology. 2000;190(3):255-66.##5.	Masztalerz M, Włodarczyk Z, Czuczejko J, Słupski M, Kedziora J, editors. Superoxide anion as a marker of ischemia-reperfusion injury of the transplanted kidney. Transplantation proceedings. Transplant Proc. 2006 Jan-Feb;38(1):46-8.##6.	Chatterjee PK. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol. 2007;376(1-2):1-43.##7.	Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem. 1998;273(23):14085-9.##8.	Kaçmaz A, Polat A, User Y, Tilki M, Özkan S, Şener G. Octreotide improves reperfusion-induced oxidative injury in acute abdominal hypertension in rats. J Gastrointest Surg. 2004;8(1):113-9.##9.	Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. The contemporary role of antioxidant therapy in attenuating liver ischemia‐reperfusion injury: A review. Liver Transplantation. 2005;11(9):1031-47.##10.	Manna P, Sinha M, Sil PC. Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid. Arch Toxicol. 2008;82(3):137-49.##11.	Lee JC, Krochak R, Blouin A, Kanterakis S, Chatterjee S, Arguiri E, et al. Dietary flaxseed prevents radiation-induced oxidative lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury. Cancer Biol Ther. 2009;8(1):47-53.##12.	Rizwan S, Naqshbandi A, Farooqui Z, Khan AA, Khan F. Protective effect of dietary flaxseed oil on arsenic-induced nephrotoxicity and oxidative damage in rat kidney. Food Chem Toxicol. 2014;68:99-107.##13.	Kitts D, Yuan Y, Wijewickreme A, Thompson L. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem. 1999;202(1-2):91-100.##14.	Khundmiri SJ, Asghar M, Banday AA, Khan F, Salim S, Levi M, et al. Effect of ischemia reperfusion on sodium-dependent phosphate transport in renal brush border membranes. Biochim Biophys Acta.2005;1716(1):19-28.##15.	Kaya H, Sezik M, Ozkaya O, Dittrich R, Siebzehnrubl E, Wildt L. Lipid peroxidation at various estradiol concentrations in human circulation during ovarian stimulation with exogenous gonadotropins. Horm Metab Res. 2004;36(10):693-5.##16.	Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem.1972;247(10):3170-5.##17.	Solez K, Kramer EC, Fox JA, Heptinstall RH. Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure. Kidney international. 1974;6(1):24-37.##18.	Aragno M, Cutrin JC, Mastrocola R, Perrelli M-G, Restivo F, Poli G, et al. Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. Kidney Int. 2003;64(3):836-43.##19.	Barnes J, Osgood R, Reineck H, Stein J. Glomerular alterations in an ischemic model of acute renal failure. Lab Invest. 1981;45(4):378.##20.	Donohoe JF, Venkatachalam MA, Bernard DB, Levinsky NG. Tubular leakage and obstruction after renal ischemia: structural-functional correlations. Kidney Int. 1978;13(3):208-22.##21.	Bonventre JV, Zuk A. Ischemic acute renal failure: An inflammatory disease&#38;quest. Kidney Int. 2004;66(2):480-5.##22.	Yano T, Nozaki Y, Kinoshita K, Hino S, Hirooka Y, Niki K, et al. The pathological role of IL-18Rα in renal ischemia/reperfusion injury. Lab Inves. 2015;95(1):78-91.##23.	Baker GL, Corry RJ, Autor A. Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Protective effect of superoxide dismutase. Ann Surg. 1985;202(5):628.##24.	Qiao X, Li R-S, Li H, Zhu G-Z, Huang X-G, Shao S, et al. Intermedin protects against renal ischemia-reperfusion injury by inhibition of oxidative stress. Am J Physiol Renal Physiol.2013;304(1):F112-F9.##25.	Valko M, Morris H, Cronin M. Metals, toxicity and oxidative stress. Current Med Chem. 2005;12(10):1161-208.##26.	Shokeir AA, Hussein AM, Awadalla A, Samy A, Abdelaziz A, Khater S, et al. Protection against renal ischaemia/reperfusion injury: A comparative experimental study of the effect of ischaemic preconditioning vs. postconditioning. Arab J of Urol. 2012;10(4):418-24.##27.	Kinniry P, Amrani Y, Vachani A, Solomides CC, Arguiri E, Workman A, et al. Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute lung injury in mice. J Nutr.. 2006;136(6):1545-51.##28.	Lee JC, Bhora F, Sun J, Cheng G, Arguiri E, Solomides CC, et al. Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol.  2008;294(2):L255-L65.##29.	Hosseinian FS, Muir AD, Westcott ND, Krol ES. AAPH-mediated antioxidant reactions of secoisolariciresinol and SDG. Org Biomol Chem. 2007;5(4):644-54.##30.	Agarwal A, Sharma RK, Desai NR, Prabakaran S, Tavares A, Sabanegh E. Role of oxidative stress in pathogenesis of varicocele and infertility. Urology. 2009;73(3):461-9. #### ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Effect of olfactory ensheathing cells (OECs) transplantation on functional recovery in acute phase of spinal contused rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Spinal cord injuries (SCI) lead to permanent irreversible functional deficits.&#160; Poor prognosis of patients is the motivation of searching a treatment for the chronic injury.&#160; Planting stem cells provides us with a promising strategy. In the meanwhile, the use of olfactory ensheathing cells (OECs) has shown very good results.&#160; This study aims at evaluating the effect of transplanted OECs on functional recovery of acute SCI in rats.

Materials and methods: In this study, eighteen adult male Wistar rats weighting approximately 210 &#177; 10 gr were used to study spinal cord injury. They were randomly divided into four groups: Sham (n = 3), Control (n = 6), Vehicle (n=3) and Treatment (n=6). In the Sham Group, only laminectomy was performed in the area of T9 spinal cord. In three groups of Control, vehicle and Treatment, after laminectomy, spinal cord contusion model was performed using the Weight drop technique. Immediately after the injury, 10&#956;l Dulbecco&#39;s Modified Eagle Medium (DMEM) alone or with 106 cells were injected to vehicle and Treatment Group animals. For culturing cells, the olfactory mucosa of 7-day-old male Wistar rats was used. Motor function of animals in all groups, was evaluated in the first 48 hours daily and then weekly for eight weeks.

Results: Comparing the results of the second to eighth week of the study showed significant differences in the group receiving the OECs with the control group (P&#60;0.05).


Conclusion: The results indicate a positive influence of the olfactory ensheathing cells in functional improvement of spinal cord injury in the acute phase of injury.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>30</FPAGE>
			<TPAGE>36</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2016/03/82015/05/242015/07/52016/05/202015/09/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1394/7/6
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2016/05/242015/07/262015/10/52016/07/162016/06/16
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1395/3/27
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Somayeh</Name>
				<MidName></MidName>
				<Family>Heidarizadi</Family>
				<NameE>Somayeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Heidarizadi</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, Faculty of  Medicine, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>azizi.moaz@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Naser</Name>
				<MidName></MidName>
				<Family>Abbasi</Family>
				<NameE>Naser</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abbasi</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of  Medicine, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>somaye6001@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Khairollah</Name>
				<MidName></MidName>
				<Family>Asadollahi</Family>
				<NameE>Khairollah</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Asadollahi</FamilyE>
				<Organizations>
				<Organization>Department of Epidemiology, Faculty of  Health, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>ilamfarma@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Sara</Name>
				<MidName></MidName>
				<Family>Rezaei</Family>
				<NameE>Sara</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rezaei</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, Faculty of  Medicine, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>masoud_1241@yahoo.co.uk</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ardeshir</Name>
				<MidName></MidName>
				<Family>Moayeri</Family>
				<NameE>Ardeshir</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moayeri</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, Faculty of  Medicine, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>rezaei7194@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Monireh</Name>
				<MidName></MidName>
				<Family>Azizi</Family>
				<NameE>Monireh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Azizi</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, Faculty of  Medicine, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>azizi.moaz@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Spinal cord injury</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Olfactory ensheathing cells</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Yaojian R, Wenxiao Z, Huijuan L, Chunxia J, Qingan Z , Yongjun W. Clinical application of olfactory ensheathing cells in the treatment of spinal cord injury. J Inter Med Res. 2013; 41(2): 473-81.##2.	Beattie MS, Hermann GE, Rogers RC, Bresnahan JC. Cell death in models of spinal cord injury. Prog Brain Res. 2002; 137:37-47.##3.	Ropper AH, Braunwald, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jaameson JL. Traumatic injuries of the head and spine: Harrison principles of internal medicine. 5th ed. New York: McGraw-Hill; 2001.P. 2441-42.##4.	Hulsebosch C. Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Edu. 2002; 26(1-4): 238-55.##5.	Makhani M. The uphill battle against spinal cord injury. MURJ. 2006; 14:7-9.##6.	Widenfalk J, Lundstromer K, Jubran M, Brene S, Olson L. Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or Kainic acid. Neuroscience. 2001; 21(10):3457-75.##7.	Woolf CJ, Salter MW. Neuronal plasticity: Increasing the gain in pain. Science. 2000; 288:1765-9.##8.	De Winter F, Oudega M, Lankhorst AJ, Hamers FP, Blits B, Ruitenberg MJ, et al. Injury include class 3 semaphorin expression in the rat spinal cord. Exp Neurol. 2002; 175(1):61-75.##9.	Ronsyn MW, Berneman ZN, Van Tendeloo VF, Jorens PG, Ponsaerts P. Can cell therapy heal a spinal cord injury? Spinal Cord. 2008:46(8):532-9.##10.	Raisman G. Olfactory ensheathing cell-another miracle cure for spinal cord injury? Nat Rev Neurosci. 2001; 2(5):369-74.##11.	Mayeur A, Duclos C, Honore A, Gauberti M, Drouot L, do Rego JC, et al. Potential of olfactory ensheathing cells from different sources for spinal cord repair. PLoS ONE.2013; 8(4): e62860.##12.	Li Y, Field PM, Raisman G. Regeneration of adult rat corticospinal axon induced by transplanted olfactory ensheathing cells. J Neurosci. 1998; 18(24):10514-24.##13.	Li Y, Field PM, Raisman G. Repair of adult rat corticospinal tract by transplant of olfactory ensheating cells. J Neurosci. 1997; 277(5334):2000-2.##14.	Verdu E, Garcia- Alias G, Joaquimfore S, Lopez-Valez R , Navarro X. Olfacrory ensheathing cells transplanted in leisoned spinal cord prevent loss of spinal cord parenchyma and promote functhional recovery. Glia. 2003; 42(3):275-86.##15.	Woodhall E, West AK, Chuah MI. Culture olfactory ensheathing cells express nerve growth factor,brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Brain Res. 2001; 88(1-2):203-13. ##16.	Lu J, Feron F, Ho SM, Mackay Sim A, Waite PM. Transplantation of nasal olfactory tissue promote partial recovery in paraplegic adult rats. Brain Res. 2001; 889(1-2):344-57.##17.	Richter WW, Flectcher PA, Liu J, Tetzlaff W, Roskams AJ. Lamina Propria and olfactory bulb ensheathing cells exhibit differential integration and migration and promote differential axon sprouting in the lesion spinal cord. Neuroscience. 2005; 25(46):10700-11.##18.	Joghataei MT, Bakhtiari M, Farahmand Ghavi F, Zandi M, Imani M. A Moaieri, et al. Purity determining of cultured OECs from olfactory mucosa of rats' pups. J Bas Res Med Sci. 2016; 3(4):12-21.##19.	Azizi M. Fabricathion of chondroitinase ABC-loaded nanoparticles and assessment of their effects in combination with OECs in the fanctional recovery in the induced SCI rats. (A PhD thesis). Iran University of Medical Sciences &#38; Health Service Faculty of Medicine. 2013:86-91.##20.	Basso DM, Beattie MS, Bresnahan JC. Grade histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transaction. Exp Neurol.1996; 139(2):244-56.##21.	Lu J, Feron F, Macky-sim A, Phil M, Wait E. Olfactory ensheathing cell promote locomotor recovery after delayed transplantation into transected spinal cord. Brain. 2002; 125(1):14-21.##22.	Lopez-Vales R, Gracia-Alias G, Fores J, Navarro X, Verdu E. Chronic transplantation of olfactory ensheathing cells promotes partial recovery after complete spinal cord transaction in the rat. Glia. 2007; 55:303-11.##23.	Tharion G, Indirani K, Durai M. Motor recovery following olfactory ensheathing cell transplantation in rats with spinal cord injury. Neurol Ind. 2011; 59(4):566-72.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Predicting the behavioral intention of pregnant women’s choice of delivery method based on the theory of planned behavior: A cross-sectional study</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Cesarean, as a major abdominal surgery, if done without a medical indication, may impose numerous complications on the mothers and the babies and increase frequency of cesarean deliveries in subsequent pregnancies. This study aimed to predict the behavioral tendencies of pregnant women in selecting their delivery approaches, based on the theory of planned behavior (TPB).

Materials and methods: This cross-sectional study was performed on 100 pregnant women referred to healthcare centers of Kermanshah city (western Iran). A researcher-made questionnaire was applied, based on TPB constructs including attitudes, perceived behavioral controls, subjective norms, and behavioral tendencies. To analyze the data, Pearson correlation, Spearman, s regression, and ANOVA were used via the SPSS statistical software, version 20.

Results: The average age of pregnant woman was 23.7&#177;3.93 years old. The results demonstrated a significant correlation between the subjective norms and behavioral tendencies (r=0.335, P=0.001). A significant relationship was seen between the perceived behavioral controls and tendencies (r=0.277, P=0.004). A significant relationship was found between the perceived behavioral control and the attitude (r=0.293, P=0.002). The results of the regression results demonstrated that the subjective norms and perceived behavioral controls can significantly predict 14.1 percent of changes in the variable of tendencie.


Conclusion: The findings indicate the strength of the variable of subjective norms as the most effective factor in predicting the delivery approach; therefore, systematic and planned training seems necessary, not only for the pregnant women, but also the individuals affecting this group. Thus, to reduce caesarean sections, physicians, as an effective factor, need to be urged to boost natural childbirth.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>37</FPAGE>
			<TPAGE>44</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2016/03/82015/05/242015/07/52016/05/202015/09/282015/12/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1394/10/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2016/05/242015/07/262015/10/52016/07/162016/06/162016/07/10
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1395/4/20
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Bahareh</Name>
				<MidName></MidName>
				<Family>Soheili</Family>
				<NameE>Bahareh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Soheili</FamilyE>
				<Organizations>
				<Organization>Department of Health Education, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>bahareh.soheili@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Amin</Name>
				<MidName></MidName>
				<Family>Mirzaei</Family>
				<NameE>Amin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mirzaei</FamilyE>
				<Organizations>
				<Organization>Department of Health Education, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Amin.mirzaei@modares.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Kourosh</Name>
				<MidName></MidName>
				<Family>Sayemiri</Family>
				<NameE>Kourosh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sayemiri</FamilyE>
				<Organizations>
				<Organization>Research Center for Prevention of Psychosocial Injuries, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>ghazanfari-z@medilam.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Zeinab</Name>
				<MidName></MidName>
				<Family>Ghazanfari</Family>
				<NameE>Zeinab</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghazanfari</FamilyE>
				<Organizations>
				<Organization>Department of Social Medicine, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>ghazanfari-z@medilam.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Natural childbirth</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cesarean section</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Theory of planned behavior</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Pregnant women</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Anjali K, Emily W, John K. Web based education and attitude to delivery by Caesarean section in nulliparous women. J Obstet Gynaecol Can. 2014;36(9):768-75.##2.	Gibbons L, Belizan J, Lauer J, Betran A, Merialdi M, Althabe F. The global numbers and costs of additionally needed and unnecessary Caesarean sections performed per year: overuse as a barrier to universal coverage. Geneva: World Health Organization. 2010.##3.	Gallagher F, Bell L, Waddell G, Benoit A, Cote N. Requesting cesareans without medical indications: an option being considered by young canadian women. Birth. 2012; 39(1):39-47.##4.	Gass CW. It is the right of every anaesthetist to refuse to participate in a maternal-request caesarean section. Int J Obstet Anesth. 2006; 15(1):33-5.##5.	Hart D, Norman J, Callander R, Govan A. Gynaecology illustrated. 5th ed. London: Churchill Livingstone. 2000:301-38.##6.	Karami-Matin B, Ataee M, Mirzaei Alavijeh M, Mahboubi M, Aghaei A, Mohammadi P. Cognitive factors related to cesarean intention among Iranian pregnant women. J Biol Todays World. 2014;3(11):251-55.##7.	Latif RR, Zakeri HM, Merghati Khoei E. Socio-cultural beliefs, values and traditions regarding women’s preferred mode of birth in the north of Iran. Int J Commun Bas Nurs Midwifery. 2015;3(3):165-76.##8.	Souza JP, Betran AP, Dumont A, de Mucio B, Gibbs Pickens CM, Deneux-Tharaux C, et al. A global reference for caesarean section rates (C-Model): a multi country cross-sectional study. Int J Obstetric Gynaecoly. 2016;123(3):427-36.##9.	Sanavi FS, Ansari-Moghaddam A, Shovey MF, Rakhshani F. Effective education to decrease elective caesarean section. J Pak Med Assoc. 2014;64(5):500-5.##10.	Perry AR, Langley C. Even with the best of intentions: paternal involvement and the theory of planned behavior. Fam Proc. 2013;52(2):179-92.##11.	Sivell S, Edwards A, Elwyn G, Manstead A. Understanding surgery choices for breast cancer: how might the Theory of Planned Behaviour and the common sense model contribute to decision support interventions? Health Expect. 2011;14(Suppl1):6-19.##12.	Tolma EL, Reininger BM, Evans A, Ureda J. Examining the theory of planned behavior and the construct of self-efficacy to predict mammography intention. Health Educ Behav. 2006;33(2):233-51.##13.	Ajzen I. Perceived behavioral control, self-efficacy, locus of control, and the Theory of Planned Behavior. J Appl Soc Psychol. 2002;32(4):665-83.##14.	Sharma M, Romas J. Theoretical foundations of health education and health promotion. 2nd ed. United States of America. Jones and Bartlet publishers. 2008.##15.	Conner M, Armitage C. Extending the theory of planned behavior: a review and avenues for further research. J Appl Soc Psychol. 1998;28(15):1429-64.##16.	Rahmati Najar Kolaei F, Eshraghi T, Dopeykar N, Zamani O, Mehdizadeh P. [Determinants of delivery type selection by using Theory of Planned Behaviors (TPB). J Urmia Nurs Midwifery. 2014;12(4):305-13]. (Persian)##17.	Sanavi FS, Rakhshani F, Ansari-Moghaddam A, Edalatian M. Reasons for elective cesarean section amongst pregnant women; A qualitative study. J Reprod Infertil. 2012;13(4):237-40.##18.	Rafati S, MadanI A, Mashayekhi F, Rafati F, Pilevarzadeh M. [Related factors to choose cesarean section among Jiroft pregnant women]. J Prevent Med. 2014; 1(1):23-30. (Persian)##19.	Besharati F, Hazavehei S, Moeini B, Moghimbeigi A. [Effect of educational interventions based on Theory of Planned Behavior (TPB) in selecting delivery mode among pregnant women referred to Rasht health centers]. J Zanjan Uni Med Sci. 2011;19 (77):94-106. (Persian)##20.	Sharifirad G, Rezaeian M, Soltani R, Javaheri S, Mazaheri MA. A survey on the effects of husbands' education of pregnant women on knowledge, attitude, and reducing elective cesarean section. J Educ Health Promot. 2013; 2:50.##21.	Salehian T, Delaram M, Safdari F, Jazayeri F. [Knowledge and attitudes of pregnant women about mode of delivery in health centers of Shahrekord]. J Toloo-e-behdasht. 2007;6(2):1-10. (Persian)## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Psychological factors related to musculoskeletal pain among Iranian female adolescents</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Musculoskeletal pain accompanied by psychological problem lead to reduce the efficiency of adolescents; so, this study aimed to determine the prevalence of musculoskeletal pain and its association with psychological factors among female adolescents.

Materials and methods: The target population of this cross sectional study was female students (3625 in total) from both private and state funded high school children in Gorgan, northern Iran. Self - assessment questionnaires were distributed to 255 students across 8 female high schools. Self-report version of the Strengths and Difficulties (SDQ) questionnaires was used to screen adolescents with Psychiatric symptoms. To evaluate musculoskeletal pain Nordic questionnaire and numeric pain rating scale was used. Data were analyzed by binary logistic regression and the cumulative odds ratio (COR) was carried out for the ordinal level of musculoskeletal symptoms.

Results: The prevalence rate of neck, shoulder and low back pain was reported, 23.1%, 27.8% and 27.7%, respectively.&#160; Hyperactivity-inattention (OR=2. 82; CI: 1.14-6.97) and peer problem (OR= 2.72; CI: 1.01-7.32) had significant relationship with neck pain, and prosocial behaviors (OR= 3.11; CI: 1.09-10.73) were associated with low back pain in the multivariate model. Ordinal regression showed that the increasing numbers of musculoskeletal symptoms related only to prosocial behavior (COR= 2.78; CI: 1.12-6.91). There was no significant association between shoulder pain and psychological factors.

Conclusion: Based on the results, psychological factors were associated with musculoskeletal pain; so, it seems suffering from musculoskeletal pain need to be concurrently noticed with mental feeling for more effective response to attenuate pain.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>45</FPAGE>
			<TPAGE>52</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2016/03/82015/05/242015/07/52016/05/202015/09/282015/12/282016/01/29
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1394/11/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2016/05/242015/07/262015/10/52016/07/162016/06/162016/07/102016/07/15
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1395/4/25
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Mohammad</Name>
				<MidName></MidName>
				<Family>Aryaie</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Aryaie</FamilyE>
				<Organizations>
				<Organization>Health Management and Social Development Research Center, Golestan University of  Medical Sciences, Gorgan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>aryaie@goums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Zahra</Name>
				<MidName></MidName>
				<Family>Khombehbini</Family>
				<NameE>Zahra</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khombehbini</FamilyE>
				<Organizations>
				<Organization>Health Management and Social Development Research Center, Golestan University of  Medical Sciences, Gorgan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>khombehbini.2013@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fozieh</Name>
				<MidName></MidName>
				<Family>Bakhsha</Family>
				<NameE>Fozieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bakhsha</FamilyE>
				<Organizations>
				<Organization>Department of Anesthesiology,  Faculty of Paramedical Sciences,  Golestan University of Medical Science, Gorgan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>bakhsha_fo@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Zahra</Name>
				<MidName></MidName>
				<Family>Yousefi</Family>
				<NameE>Zahra</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Yousefi</FamilyE>
				<Organizations>
				<Organization>Department of Anesthesiology,  Faculty of Paramedical Sciences,  Golestan University of Medical Science, Gorgan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>stu.yousefi@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Omid</Name>
				<MidName></MidName>
				<Family>Behravesh</Family>
				<NameE>Omid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Behravesh</FamilyE>
				<Organizations>
				<Organization>Department of Anesthesiology,  Faculty of Paramedical Sciences,  Golestan University of Medical Science, Gorgan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>omidbehravesh1344@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Psychological problems</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Neck</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Shoulder</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Low back pain</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Astfalck RG, O'Sullivan PB, Straker LM, Smith AJ. A detailed characterisation of pain, disability, physical and psychological features of a small group of adolescents with non-specific chronic low back pain. Man Ther. 2010 Jun;15(3):240-7.##2.	E-Metwally A, Salminen JJ, Auvinen A, Macfarlane G, Mikkelsson M. Risk factors for development of non-specific musculoskeletal pain in preteens and early adolescents: a prospective 1-year follow-up study. BMC Musculoskelet Disord. 2007;8(1):46.##3.	Mohammadi MR, Arman S, Dastjerdi JK, Salmanian M, Ahmadi N, Ghanizadeh A, et al. Psychological Problems in Iranian Adolescents: Application of the Self Report Form of Strengths and Difficulties Questionnaire. Iran J Psychiatry. 2013; 8(4):152-9.##4.	Yao W, Luo C, Ai F, Chen Q. Risk Factors for Nonspecific Low‐Back Pain in Chinese Adolescents: A Case‐Control Study. Pain Med. 2012; 13(5):658-64.##5.	Nieto Rn, Raichle KA, Jensen MP, Miro J. Changes in pain-related beliefs, coping, and catastrophizing predict changes in pain intensity, pain interference, and psychological functioning in individuals with myotonic muscular dystrophy and facioscapulohumeral dystrophy. Clin J Pain. 2012; 28(1):47-54.##6.	Shan Z, Deng G, Li J, Li Y, Zhang Y, Zhao Q. Correlational Analysis of neck/shoulder Pain and Low Back Pain with the Use of Digital Products, Physical Activity and Psychological Status among Adolescents in Shanghai. PloS One. 2013;8(10):e78109.##7.	Spyropoulos P, Papathanasiou G, Georgoudis G, Chronopoulos E, Koutis H, Koumoutsou F. Prevalence of low back pain in Greek public office workers. Pain Physic. 2007;10(5):651.##8.	Auvinen JP, Tammelin TH, Taimela SP, Zitting PJ, Jarvelin M-R, Taanila AM, et al. Is insufficient quantity and quality of sleep a risk factor for neck, shoulder and low back pain? A longitudinal study among adolescents. Eur Spine J. 2010; 19(4):641-9.##9.	Pollock CM, Harries RL, Smith AJ, Straker LM, Kendall GE, Sullivan PB. Neck/shoulder pain is more strongly related to depressed mood in adolescent girls than in boys. Man Ther. 2011 Jun;16(3):246-51.##10.	Gunilla M, Sundblad B, Saartok Tn, T. Engstrom. Prevalence and co-occurrence of self-rated pain and perceived health in school-children: Age and gender differences. Eur J Pain. 2007;11(2):171-80.##11.	Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry. 2003; 60(8):837-44.##12.	Sawyer MG, Arney FM, Baghurst PA, Clark JJ, Graetz BW, Kosky RJ, et al. The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-being. Aust N Z J Psychiatry. 2001;35(6):806-14.##13.	Diepenmaat A, Van der Wal M, De Vet H, Hirasing R. Neck/shoulder, low back, and arm pain in relation to computer use, physical activity, stress, and depression among Dutch adolescents. Pediatrics. 2006;117(2):412-6.##14.	Harma A-M, Kaltiala-Heino R, Rimpela M, Rantanen P. Are adolescents with frequent pain symptoms more depressed? Scand J Prim Health Care. 2002;20(2):92-6.##15.	Mikkelsson M, Sourander A, Piha J, Salminen JJ. Psychiatric symptoms in preadolescents with musculoskeletal pain and fibromyalgia. Pediatrics. 1997; 100(2):220-7.##16.	Chiu TT, Lam T-H, Hedley AJ. Maximal isometric muscle strength of the cervical spine in healthy volunteers. Clin  Rehabil. 2002;16(7):772-9.##17.	Torgen M, Swerup C. Individual factors and physical work load in relation to sensory thresholds in a middle-aged general population sample. Eur J Appl Physiol. 2002; 86(5):418-27.##18.	Wijnhoven HAH, de Vet HCW, Picavet HSJ. Explaining sex differences in chronic musculoskeletal pain in a general population. Pain. 2006; 124(1):158-66.##19.	Wedderkopp N, Andersen LB, Froberg K, Leboeuf-Yde C. Back pain reporting in young girls appears to be puberty-related. BMC Musculoskelet  Disord. 2005;6(1):52.##20.	Shamsedini A, Hellisaz MT, Dalvand H, Khatibi A, Sobhani V. The investigation of prevalence of musculoskeletal symptoms and discomfort caused by them in students of Tehran. HBI J. 2011;8(4):271-6.##21.	Naghavi M, Abolhassani F, Pourmalek F, Lakeh MM, Jafari N, Vaseghi S, et al. The burden of disease and injury in Iran 2003. Popul Health Metr. 2009;7(1):9.##22.	Shahrivar Z, Tehrani-Doost M, Pakbaz B, Rezaie A, Ahmadi F. Normative data and psychometric properties of the parent and teacher versions of the strengths and difficulties questionnaire (SDQ) in an Iranian community sample. J Res  Med  Sci. 2009;14(2):69-77.##23.	Aryaie M, Roshandel G, Semnani S, Asadi-Lari M, Aarabi M, Vakili MA, et al. Predictors of Colorectal Cancer Survival in Golestan, Iran: A Population-based Study. Epidemiol Health. 2013;35:e2013004.##24.	Ghanizadeh A, Izadpanah A, Abdollahi G. Scale validation of the strengths and difficulties questionnaire in Iranian children. Iran J Physic. 2007; (2):65-71.##25.	Jussila L, Paananen M, Nayha S, Taimela S, Tammelin T, Auvinen J, et al. Psychosocial and lifestyle correlates of musculoskeletal pain patterns in adolescence: A 2 year followo up study. Eur J Pain. 2014;18(1):139-46.##26.	Rees CS, Smith AJ, O'Sullivan PB, Kendall GE, Straker LM. Back and neck pain are related to mental health problems in adolescence. BMC Public Health. 2011;11(1):382.##27.	Bruusgaard D, Smedbraten BK, Natvig B. Bodily pain, sleep problems and mental distress in schoolchildren. Acta Paediatrica. 2000;89(5):598-600.##28.	Jones GT, Silman AJ, Macfarlane GJ. Predicting the onset of widespread body pain among children. Arthritis Rheum. 2003;48(9):2615-21.##29.	Larsson B, Sund AM. Emotional/behavioural, social correlates and one year predictors of frequent pains among early adolescents: Influences of pain characteristics. Eur J Pain. 2007;11(1):57-65.##30.	Stanford EA, Chambers CT, Biesanz JC, Chen E. The frequency, trajectories and predictors of adolescent recurrent pain: a population-based approach. Pain. 2008;138(1):11-21.##31.	Bergbom S, Boersma K, Linton SJ. Both early and late changes in psychological variables relate to treatment outcome for musculoskeletal pain patients at risk for disability. Behav Res Therap. 2012;50(11):726-34.##32.	Sullivan MJL, Adams H, Thibault P, Corbire M, Stanish WD. Initial depression severity and the trajectory of recovery following cognitive-behavioral intervention for work disability. J Occup Rehabil. 2006;16(1):60-71.##33.	Speckens AE, Van Hemert AM, Spinhoven P, Hawton KE, Bolk JH, Rooijmans HG. Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trial. BMJ. 1995;311(7016):1328-32.##34.	Williams C, Wilson P, Morrison J, McMahon A, Andrew W, Allan L, et al. Guided self-help cognitive behavioural therapy for depression in primary care: a randomised controlled trial. PloS One. 2013; 8(1):e52735.##35.	Nielsen LA, Henriksson KG. Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition. Best Pract Res Clin Rheumatol. 2007; 21(3):465-80.##36.	Balagu F, Dudler J, Nordin M. Low-back pain in children. Lancet. 2003;361(9367):1403-4.##37.	Watson KD, Papageorgiou AC, Jones GT, Taylor S, Symmons DPM, Silman AJ, et al. Low back pain in schoolchildren: the role of mechanical and psychosocial factors. Arch Dis Child. 2003;88(1):12-7.##38.	Siivola SM, Levoska S, Latvala K, Hoskio E, Vanharanta H, Keinanen-Kiukaanniemi S. Predictive factors for neck and shoulder pain: a longitudinal study in young adults. Spine. 2004; 29(15):1662-9.##39.	Roh YH, Noh JH, Oh JH, Baek GH, Gong HS. To what degree do shoulder outcome instruments reflect patients’ psychologic distress? Clin Orthop Relat Res. 2012;470(12):3470-7.##40.	Roh YH, Lee BK, Noh JH, Oh JH, Gong HS, Baek GH. Effect of depressive symptoms on perceived disability in patients with chronic shoulder pain. Arch Orthop Trauma Surg. 2012; 132(9):1251-7.##41.	Murphy S, Buckle P, Stubbs D. A cross-sectional study of self-reported back and neck pain among English schoolchildren and associated physical and psychological risk factors. Appl Ergon. 2007;38(6):797-804.##42.	O'Sullivan PB, Straker LM, Smith A, Perry M, Kendall G. Carer experience of back pain is associated with adolescent back pain experience even when controlling for other carer and family factors. Clin J Pain. 2008; 24(3):226-31.##43.	Helmus M, Schiphorst Preuper HR, Hof AL, Geertzen JHB, Reneman MF. Psychological factors unrelated to activity level in patients with chronic musculoskeletal pain. Eur J Pain. 2011;16(8):1158-65.##44.	Badcock LJ, Lewis M, Hay EM, McCarney R, Croft PR. Chronic shoulder pain in the community: a syndrome of disability or distress? Ann Rheum Dis. 2002;61(2):128-31.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Investigating the prevalence rate of hypertension in Iranian men and women: A study of systematic review and meta-analysis</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Based on the serious complications which are followed, hypertension is a common and asymptomatic health problem. This study aims to present a general statistics of the rate of the prevalence of systolic and diastolic hypertension in Iranian men and women based on the age range through the systematic review and meta-analysis method.

Materials and methods: In this study of systematic review and meta-analysis, some databases such as Google Scholar, Scope.com, Magiran, Iran Medex, Medlib, Sid, and Pubmed were searched by using keywords such as hypertension, men and women, Iran, and prevalence. The first and the last published articles in this field were in 1999 and 2012, respectively. Data were combined by random effects meta-analysis model and they were analyzed by STATA11.

Results: From 100 articles which were found in the searched references, 22 of them were finally analyzed. Among the selected final articles from 1999 to 2012, 96689 subjects were used in this study. The mean prevalence of hypertension was 17% (confidence coefficient of 95%, 17-17%). The prevalence rate of hypertension among the people above 20 was between 10-32% and its mean was 24% (confidence coefficient of 95%, 23-24%). The mean prevalence of hypertension among the people below 20 was 5% (confidence coefficient of 95%, 4-5%).

Conclusion: In the studies done in Iran, the prevalence rate of hypertension was high. Noticing that hypertension is an important and dangerous factor for cardiovascular diseases, it is a worrying issue in Iran and it is necessary to be programmed in order to control and prevent this disease.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>53</FPAGE>
			<TPAGE>62</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2016/03/82015/05/242015/07/52016/05/202015/09/282015/12/282016/01/292015/09/29
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1394/7/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2016/05/242015/07/262015/10/52016/07/162016/06/162016/07/102016/07/152016/04/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1395/2/9
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Yousof</Name>
				<MidName></MidName>
				<Family>Mohsenzadeh</Family>
				<NameE>Yousof</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mohsenzadeh</FamilyE>
				<Organizations>
				<Organization>Department of Cardiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Morteza</Name>
				<MidName></MidName>
				<Family>Motedayen</Family>
				<NameE>Morteza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Motedayen</FamilyE>
				<Organizations>
				<Organization>Department of Cardiology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Farhad</Name>
				<MidName></MidName>
				<Family>Hemmati</Family>
				<NameE>Farhad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hemmati</FamilyE>
				<Organizations>
				<Organization>Department of Sports Medicine, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Kourosh</Name>
				<MidName></MidName>
				<Family>Sayehmiri</Family>
				<NameE>Kourosh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sayehmiri</FamilyE>
				<Organizations>
				<Organization>Department of Biostatistics, Psychosocial Injuries Research Center, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad Taher</Name>
				<MidName></MidName>
				<Family>Sarokhani</Family>
				<NameE>Mohammad Taher</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sarokhani</FamilyE>
				<Organizations>
				<Organization>Psychosocial Injuries Research Center, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Diana</Name>
				<MidName></MidName>
				<Family>Sarokhani</Family>
				<NameE>Diana</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sarokhani</FamilyE>
				<Organizations>
				<Organization>Psychosocial Injuries Research Center, Ilam University of Medical Sciences, Ilam, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Hypertension</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Men and Women</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Iran</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Prevalence</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Ahmadi A, Hasanzadeh J, Rajaefard A. To Determine the Relative Factors on Hypertension in Kohrang, Chaharmahal &#38; Bakhtiari Province, 2007. Iran J Epidemiol. 2008;4(2):19-25.##2.	Behforuz M, Sajjadi  M, Sayadi  A. [Prevalence, awareness, treatment and control of hypertension in people over 18 years of Rafsanjan city]. J Rafsenjan Uni Med Sci. 2002;1(2):85-91. (Persian)##3.	Kalani  Z, Abdi  H, Shahbazi  L, Salimi  T, Amini Poor  M. [Hypertension in the yazd adult population]. Payesh. 2011;10(1):101-7. (Persian)##4.	Pezhhan  A, Najar  L, Heydari  A. [Study of the prevalence of hypertension in the urban population of sabzevar Iran]. J  Sabzevar Uni Med Sci. 2008;15(1):26-32. (Persian)##5.	Sohrabi  M, Heidarnia  M, Mehrabi  I, Abolhasani  F. [Evaluation of the coverage of National Hypertension Prevention and Control Program in Damavand]. Pejouhesh. 2007;31(3):255-61. (Persian)##6.	Farajzadeh  Z, Kaheni  S, Saadatjoo  S. [The relationship between level of stress and hypertension- overcoming strategies]. J Birjand Uni Med Sci. 2005;12(1):9-15. (Persian)##7.	Goodarzi  M, Badakhsh  M, Masinaei Nejad  N, Abbas Zadeh M. [Hypertension Prevalence in Over 18-Year-Old Population of Zabol]. Razi J Med Sci. 2004;11(43):821-7. (Persian)##8.	Mansoorian  M, Qorbani  M, Shafieyan  N, Asayesh  H. Association between life style and hypertension in rural population of Gorgan. J Health Promot Manag. 2012;1(2):23-8.##9.	Araghchian  M, Seif Rabie  M, Zeraati  F, Rasouli  B. [The Survey of Depression Frequency in Hypertensive Patients]. J Hamadan Uni Med Sci. 2009;16(4):37-41. (Persian)##10.	Ebadi  A, Shamsi  A, Refahi  A, Saied  Y. [Comparison of the Quality of Life in Men with and Without Hypertension]. Nasim-Danesh. 2012;20(1):5-15. (Persian)##11.	Gaffari  F, Zeighami Mohammadi  S. [Frequency of daytime sleepiness in hypertensive women]. Nasim-Danesh. 2011;19(1):5-15. (Persian)##12.	Mehr-Alizadeh  S, Ghorbani  R, Sharafi  S. [Prevalence of hypertension in 9-17 years old schoolchildren in Iranian population]. J Koomesh 2010;12(1):1-7. (Persian)##13.	Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007;45(4):247-51.##14.	Fakhrzade  H. Prevalence of hypertension and associated risk factors in an urban population 24-25 years old population research center in Tehran University of Medical Sciences. Iran J Diabete Lipid. 2012; 3:42-9.##15.	Meraci  M, Feizei  A, Bager Nejad  M. Investigating the prevalence of high blood pressure, type 2 diabetes mellitus and related risk factors according to a large general study in Isfahan- using multivariate logistic regression model. Health Sys Res. 2012;8(2):193-202.##16.	Moradmand  S. [The prevalence of hypertension and its association with birth weight and current students in Tehran]. Paramed  Facult Tehran Uni Med Sci. 2011;5:16-23. (Persian)##17.	Sharifi F, Mirarefin M, Fakhrzadeh H, Saadat S, Ghaderpanahi M, Badamchizade Z. Prevalence of hypertension and diabetes in elderly: elderly kahrizak study (Brief communication). J Diabete Metab Disord. 2010;4(11):16-29.##18.	Ghorbani R, Askandarian R, Malek M, Rashidy-pour A. Prevalence of Hypertension among the Adult Population of Semnan Province. Iran J Endocrinol  Metab. 2009;10(5):495-503.##19.	Delavari    A, Horri  N, Alikhani  S, Guya  M, Mahdavi  A, Hoseini  M, et al. [The prevalence of hypertension in urban and rural population aged 20 years and Iran in 2004]. J Mazandaran Uni Med Sci. 2014;17(1): 79-86.##20.	Salem Z. [Prevalence of Hypertension and its association with the anthropometric indices in adolescent girls in Rafsanjan], 2007. J Rafsanjan Uni Med Sci. 2009;8(4):273-86.##21.	Beygzadeh  S, Zareei  S, Pourahmadi  M. [The prevalence of hypertension and factors affecting it in Jahrom City]. Pars J  Med  Sci. 2009;7(2):39-47. (Persian)##22.	Zrdast  M, Namakin  K, Taheri  F, Chahkandi  T, Bijari  B, Kazemi  T. [Prevalence of high blood pressure in primary school children in Birjand-Iran]. J Birjand Uni Med Sci. 2013;19(6):61-8. (Persian)##23.	Sadeghi  M, Rouhafza  H, Sadri  GH, Bahonar  A, Saadi  M, ASGARI  S, et al. [Prevalence of high blood pressure and its relation with cardiovascular risk factors]. J Qazvin Uni Med Sci. 2003(26):46-52. (Persian)##24.	Zare  M, Abedi  K, Rahiminezhad  M, Halvani  GH, Barkhordari  A, Valipour  E. [Influence of aircraft noise on hypertension in airport staff]. J Babol Uni Med Sci. 2009;10(6):54-61. (Persian)##25.	Keshavarzi  S, Zare  N. [Comparing the two methods, regression to estimate the odds ratio of systolic and diastolic blood pressure in the study of risk factors in adolescents and adults in Shiraz]. J Knowledge. 2011;17: 22-30. (Persian)##26.	Bashar DA. [The relationship between blood pressure and weight gain between hemodialysis sessions in dialysis patients dialysis centers Bu-Ali hospital in Ardebil]. J Ardabil. 2007;7:22-6. (Persian)##27.	Koushki  A, Aminpour  A, Azar  M, Kalantari  N, Ardekani  H. [The effect of drinking Damavand mineral water on sodium, magnesium and calcium cations in men with hypertension]. J Asrar. 2003;9(4):31-8. (Persian)##28.	Chaman R. [The prevalence of hypertension and associated factors in a sample of rural population with ethnic diversity]. J Shahrood Uni Med Sci. 2008;3(3,4):39-42. (Persian)##29.	Ataei N, Aghamohammadi A, Ziaee V, Hosseini M, Dehsara F, Rezanejad A. Prevalence of hypertension in junior and senior high school children in Iran. Iran J Pediatr. 2008;17:237-42.##30.	Javadi  H. [Evaluationaf awareness, treatment, and drug consumption in hypertensives]. J  Qazvin Uni Med Sci. 2009;12:59-64. (Persian)##31.	Khani   M, Vakili  M, Ansari A. [The prevalence of hypertension and its related risk factors in rural population covered by health network city Tarom, 2001]. The J Zanjan Uni Med Sci. 2002:23-8. (Persian)##32.	Abdollahy  A, Bazrafshan  H, Salehi  A, Behnampour  N, Hosayni  S, Rahmany  H, et al. [Epidemiology of hypertension among urban population in Golestan province in north of Iran]. J Gorgan Uni Med Sci. 2007;8(4):37-41. (Persian)##33.	Veghari  G, Joshaghani  H, Hoseini  S, Sedaghat  S, Niknezhad  F, Angizeh  A, et al. [People awareness of hypertension in Golestan province, North of Iran (2006)]. J Gorgan Uni Med Sci. 2011;13(2):68-78. (Persian)##34.	Azizi A, Abasi M, Abdoli G. The prevalence of hypertension and its association with age, sex and BMI in a population being educated using community-based medicine in Kermanshah: 2003. Iran J Endocrinol Metab. 2008;10(4):323-9.##35.	Paknahad Z, Saboktagin M. [Studying the blood pressure in Isfahan rural residents and its relationship with BMI]. Health Sys Res. 2010;6(3):506-12. (Persian)##36.	Baroogh N, Teimouri F, Saffari M, Sadeh S, Mehran A. [Hypertension and lifestyle in 24-65 year old people in Qazvin Kosar region in 2007]. Pajoohandeh J. 2010;15(5):193-8. (Persian)##37.	Fattahi F, Behrouzi M, Zarrati M. [Relation of body mass index, abdominal obesity, some nutritional habits and hypertension in 25-65 year old population of Tehran]. Koomesh 2011;12(3):229-35. (Persian)## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
